Benign Metastasizing Leiomyoma

Area of Science:

• Gynecologic Oncology
• Pathology
• Pulmonary Medicine

Background:

• Benign metastasizing leiomyoma (BML) is a rare entity, primarily affecting women with a history of uterine leiomyomata.
• Metastasis typically occurs in the lungs, though other sites are possible.
• Patients are often of reproductive or perimenopausal age and may have undergone prior uterine surgery.

Observation:

• BML presents with indolent clinical courses, but growing nodules can cause pulmonary symptoms.
• Accurate differentiation from malignant conditions like leiomyosarcoma is crucial for appropriate patient management.
• Hormonal suppression is a recognized therapeutic strategy for BML.

Findings:

• Uterine leiomyomata can exhibit benign distant metastasis, most commonly to the lungs.
• The condition often presents in women with a history of hysterectomy or myomectomy.
• Pulmonary symptoms arise from the size and number of metastatic nodules.

Implications:

• Distinguishing BML from malignancy prevents overtreatment and ensures timely management.
• Hormonal therapy demonstrates efficacy in reducing BML lesion size and improving respiratory function.
• Understanding BML's behavior is vital for gynecologic oncologists and pulmonologists.